Product Reports Resources Pricing Login Book a demo

Tempus

Biotech & Life Sciences · Chicago, United States · Founded 2015 · IPO 2024

A technology company advancing precision medicine through the practical application of artificial intelligence in healthcare

Valuation $8.54B
Revenue $1.59B

Investors

9 investors on Tempus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Lightbank
Series B+ 8 investors entered at this stage

Global footprint

Where Tempus has talent and traffic

Workforce by country
23 countries with
team presence
🇺🇸 United States97.6%
🇨🇦 Canada0.7%
🇪🇸 Spain0.5%
🇬🇧 United Kingdom0.2%
🇫🇷 France0.1%
Top 5 of 23 shown
Web traffic by country
130K monthly visits
across markets
🇺🇸 United States43.8%
🇨🇦 Canada6.2%
🏳️ Korea4.2%
🏳️ Republic of3.8%
🇮🇳 India3.5%
Top 5 markets shown

Talent graph

The shape of Tempus's talent

Dealroom maps Tempus's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

56 standout operatorsDealroom-flagged across the org
104 AI specialistsincl. 39 core researchers
3,068 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Tempus's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$116M patent portfolio · 269 active families

Estimated portfolio value
$116M
1.4% of market cap · 2.5× smaller than top peer Verily ($295M)
269 active patent families
Where Tempus innovates BioinformaticsComputational biologyComputer visionControl unitData mining

Where Tempus concentrates vs peers

Each axis is a top-10 topic across Tempus and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Tempus's 4 investments and acquisitions.

Every disclosed deal where Tempus appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Tempus's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Tempus deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Tempus's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Tempus

        An AI-synthesized read of the highest-engagement posts about Tempus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Tempus on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.